MATINAS BIOPHARMA HOLDINGS, INC. Debt Securities, Available-for-sale, Amortized Cost
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) had Debt Securities, Available-for-sale, Amortized Cost of $500.00 thousand as of 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2025-04-15
- 2024-09-30: Debt Securities, Available-for-sale, Amortized Cost $500.00K.
- 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost $10.15M.
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $7.17M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $9.19M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2024-09-30 | $500.00K 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $10.15M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $7.17M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $9.19M 10-K · filed 2025-04-15 | |
| 2023-09-30 | $12.17M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $13.28M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $19.71M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $22.76M 10-K · filed 2024-03-27 | |
| 2022-09-30 | $22.81K 10-Q · filed 2022-11-02 | |
| 2022-03-31 | $28.86M 10-Q · filed 2022-08-11 | $25.17M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $28.74K 10-K · filed 2023-03-15 | $28.74M 10-K · filed 2022-03-08 |
| 2021-09-30 | $28.91M 10-Q · filed 2021-11-08 | |
| 2020-12-31 | $46.02M 10-K/A · filed 2022-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B |